Compare CADL & BTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | BTGO |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 496.1M |
| IPO Year | 2021 | 2025 |
| Metric | CADL | BTGO |
|---|---|---|
| Price | $4.99 | $3.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $17.67 | $8.88 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.14 |
| P/E Ratio | ★ N/A | $10.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $3.48 |
| 52 Week High | $14.00 | $15.30 |
| Indicator | CADL | BTGO |
|---|---|---|
| Relative Strength Index (RSI) | 25.65 | 24.00 |
| Support Level | $4.62 | N/A |
| Resistance Level | $5.51 | $5.72 |
| Average True Range (ATR) | 0.70 | 0.39 |
| MACD | -0.33 | -0.08 |
| Stochastic Oscillator | 1.62 | 2.60 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.